{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:15:41Z","timestamp":1793924141932,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04010-7","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:48:41Z","timestamp":1761119321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-7699","authenticated-orcid":false,"given":"Mojtaba","family":"Esmaeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8298-4975","authenticated-orcid":false,"given":"Maryam","family":"Dehghanpour Dehabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"1","key":"4010_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4010_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18081\/2333-5106\/2025.1\/1","volume":"13","author":"H Begum","year":"2025","unstructured":"Begum H, Sheikh K, Kumar M, Masood I, Khokhar A. International cancer burden analysis 2020\u20132024: GLOBOCAN-derived estimates of incidence and mortality for 30 malignancies in 190 geographic regions. Am J Biomed. 2025;13:1\u201318.","journal-title":"Am J Biomed"},{"issue":"3","key":"4010_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"4010_CR4","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.3390\/cancers16213603","volume":"16","author":"J Malhotra","year":"2024","unstructured":"Malhotra J, Huang A, Amini A, Lee P. Novel immunotherapeutics for the treatment of non-small cell lung cancer (NSCLC) resistant to PD-1\/PD-L1 inhibitors. Cancers. 2024;16(21):3603.","journal-title":"Cancers"},{"key":"4010_CR5","volume":"312","author":"M Sodergren","year":"2024","unstructured":"Sodergren M, Mangal N. Cannabidiol as a chemotherapy adjunct in cancer treatment. Pharm J. 2024;312:7983.","journal-title":"Pharm J"},{"issue":"8","key":"4010_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0269881108096519","volume":"23","author":"AW Zuardi","year":"2009","unstructured":"Zuardi AW, Crippa J, Hallak JEC, Pinto J, Chagas MHN, Rodrigues G, et al. Cannabidiol for the treatment of psychosis in Parkinson\u2019s disease. J Psychopharmacol. 2009;23(8):979\u201383.","journal-title":"J Psychopharmacol"},{"issue":"11","key":"4010_CR7","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3390\/cancers12113203","volume":"12","author":"ES Seltzer","year":"2020","unstructured":"Seltzer ES, Watters AK, MacKenzie D, Granat LM, Zhang D. Cannabidiol (CBD) as a promising anti-cancer drug. Cancers. 2020;12(11):3203.","journal-title":"Cancers"},{"issue":"1","key":"4010_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42238-025-00289-5","volume":"7","author":"SS Alghamdi","year":"2025","unstructured":"Alghamdi SS, Albahlal HN, Aloumi DE, Bin Saqyah S, Alsubait A, Alamre J, et al. Revealing the therapeutic potential of synthetic cannabinoids: a systematic review of cannabinoid receptor binding dynamics and their implications for cancer therapy. J Cannabis Res. 2025;7(1):33.","journal-title":"J Cannabis Res"},{"issue":"6","key":"4010_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/biology11060817","volume":"11","author":"CG Heider","year":"2022","unstructured":"Heider CG, Itenberg SA, Rao J, Ma H, Wu X. Mechanisms of cannabidiol (CBD) in cancer treatment: a review. Biology. 2022;11(6):817.","journal-title":"Biology"},{"key":"4010_CR10","doi-asserted-by":"publisher","first-page":"725136","DOI":"10.3389\/fphar.2021.725136","volume":"12","author":"C Gross","year":"2021","unstructured":"Gross C, Ramirez DA, McGrath S, Gustafson DL. Cannabidiol induces apoptosis and perturbs mitochondrial function in human and canine glioma cells. Front Pharmacol. 2021;12:725136.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4010_CR11","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.1038\/s41467-024-51884-8","volume":"15","author":"E Puighermanal","year":"2024","unstructured":"Puighermanal E, Luna-S\u00e1nchez M, Gella A, van der Walt G, Urpi A, Royo M, et al. Cannabidiol ameliorates mitochondrial disease via PPAR\u03b3 activation in preclinical models. Nat Commun. 2024;15(1):7730.","journal-title":"Nat Commun"},{"issue":"1","key":"4010_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05477-0","volume":"22","author":"S Feng","year":"2024","unstructured":"Feng S, Pan Y, Lu P, Li N, Zhu W, Hao Z. From bench to bedside: the application of Cannabidiol in glioma. J Transl Med. 2024;22(1):648.","journal-title":"J Transl Med"},{"key":"4010_CR13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116749","author":"T Strong","year":"2018","unstructured":"Strong T, Rauvolfova J, Jackson E, Pham LV, Bryant J. Synergistic effect of cannabidiol with conventional chemotherapy treatment. Blood. 2018. https:\/\/doi.org\/10.1182\/blood-2018-99-116749.","journal-title":"Blood"},{"issue":"58","key":"4010_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/jncimonographs\/lgab007","volume":"2021","author":"SJ Ward","year":"2021","unstructured":"Ward SJ, Lichtman AH, Piomelli D, Parker LA. Cannabinoids and cancer chemotherapy-associated adverse effects. JNCI Monogr. 2021;2021(58):78\u201385.","journal-title":"JNCI Monogr"},{"issue":"10","key":"4010_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244195","volume":"14","author":"KL Liew","year":"2021","unstructured":"Liew KL, Capuano E, Yung B. Lung cancer patient who had declined conventional cancer treatment: could the self-administration of \u2018CBD oil\u2019be contributing to the observed tumour regression? BMJ Case Rep. 2021;14(10):e244195.","journal-title":"BMJ Case Rep"},{"key":"4010_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fpls.2019.00697","volume":"10","author":"A Mead","year":"2019","unstructured":"Mead A. Legal and regulatory issues governing cannabis and cannabis-derived products in the United States. Front Plant Sci. 2019;10:697.","journal-title":"Front Plant Sci"},{"issue":"6","key":"4010_CR17","volume":"20","author":"D Turck","year":"2022","unstructured":"EFSA Panel on, Nutrition NF, Allergens F, Turck D, Bohn T, Castenmiller J, De Henauw S, et al. Statement on safety of cannabidiol as a novel food: data gaps and uncertainties. EFSA J. 2022;20(6):e07322.","journal-title":"EFSA J"},{"issue":"1","key":"4010_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbrc.2007.09.107","volume":"364","author":"A Athanasiou","year":"2007","unstructured":"Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, et al. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun. 2007;364(1):131\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"4010_CR19","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s11095-010-0219-2","volume":"27","author":"R Ramer","year":"2010","unstructured":"Ramer R, Rohde A, Merkord J, Rohde H, Hinz B. Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of Cannabidiol on human lung cancer cells. Pharm Res. 2010;27(10):2162\u201374.","journal-title":"Pharm Res"},{"issue":"1","key":"4010_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","volume":"12","author":"R Ramer","year":"2013","unstructured":"Ramer R, Heinemann K, Merkord J, Rohde H, Salamon A, Linnebacher M, et al. COX-2 and PPAR-\u03b3 confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013;12(1):69\u201382.","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"4010_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/ph14111169","volume":"14","author":"H Hamad","year":"2021","unstructured":"Hamad H, Olsen BB. Cannabidiol induces cell death in human lung cancer cells and cancer stem cells. Pharmaceuticals. 2021;14(11):1169.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"4010_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/cancers14051181","volume":"14","author":"S Misri","year":"2022","unstructured":"Misri S, Kaul K, Mishra S, Charan M, Verma AK, Barr MP, et al. Cannabidiol inhibits tumorigenesis in cisplatin-resistant non-small cell lung cancer via TRPV2. Cancers. 2022;14(5):1181.","journal-title":"Cancers"},{"issue":"12","key":"4010_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126766","volume":"23","author":"L Milian","year":"2022","unstructured":"Milian L, Monleon-Guinot I, Sancho-Tello M, Galbis JM, Cremades A, Almenar-Ordaz M, et al. In vitro effect of \u22069-tetrahydrocannabinol and cannabidiol on cancer-associated fibroblasts isolated from lung cancer. Int J Mol Sci. 2022;23(12):6766.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4010_CR24","doi-asserted-by":"publisher","first-page":"e0228909","DOI":"10.1371\/journal.pone.0228909","volume":"15","author":"L Milian","year":"2020","unstructured":"Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Mart\u00edn de Llano JJ, et al. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. PLoS ONE. 2020;15(2):e0228909.","journal-title":"PLoS ONE"},{"key":"4010_CR25","doi-asserted-by":"publisher","first-page":"1268652","DOI":"10.3389\/fimmu.2024.1268652","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Sharma A, Hoffmann MJ, Skowasch D, Essler M, Weiher H, et al. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells. Front Immunol. 2024;15:1268652.","journal-title":"Front Immunol"},{"issue":"7","key":"4010_CR26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ph15070836","volume":"15","author":"Y-J Park","year":"2022","unstructured":"Park Y-J, Na H-H, Kwon I-S, Hwang Y-N, Park H-J, Kwon T-H, et al. Cannabidiol regulates PPAR\u03b3-dependent vesicle formation as well as cell death in A549 human lung cancer cells. Pharmaceuticals. 2022;15(7):836.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"4010_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.onc.1210641","volume":"27","author":"A Preet","year":"2008","unstructured":"Preet A, Ganju R, Groopman J. \u22069-tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene. 2008;27(3):339\u201346.","journal-title":"Oncogene"},{"issue":"1","key":"4010_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-10-0181","volume":"4","author":"A Preet","year":"2011","unstructured":"Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, et al. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non\u2013small cell lung cancer growth and metastasis. Cancer Prev Res. 2011;4(1):65\u201375.","journal-title":"Cancer Prev Res"},{"issue":"12","key":"4010_CR29","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/mc.22451","volume":"55","author":"J Ravi","year":"2016","unstructured":"Ravi J, Elbaz M, Wani NA, Nasser MW, Ganju RK. Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non\u2010small cell lung cancer by downregulation of EGFR pathway. Mol Carcinog. 2016;55(12):2063\u201376.","journal-title":"Mol Carcinog"},{"key":"4010_CR30","doi-asserted-by":"publisher","first-page":"997115","DOI":"10.3389\/fimmu.2022.997115","volume":"13","author":"A Sarsembayeva","year":"2023","unstructured":"Sarsembayeva A, Kienzl M, Gruden E, Ristic D, Maitz K, Valadez-Cosmes P, et al. Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8\u2009+\u2009T and NK cells. Front Immunol. 2023;13:997115.","journal-title":"Front Immunol"},{"key":"4010_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X19832160","volume":"7","author":"J Sul\u00e9-Suso","year":"2019","unstructured":"Sul\u00e9-Suso J, Watson NA, van Pittius DG, Jegannathen A. Striking lung cancer response to self-administration of cannabidiol: a case report and literature review. SAGE Open Med Case Rep. 2019;7:2050313X19832160.","journal-title":"SAGE Open Med Case Rep"},{"key":"4010_CR32","doi-asserted-by":"crossref","unstructured":"Ramer R, Rohde A, Merkord J, Rohde H, Hinz B. Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of Cannabidiol on human lung cancer cells. Pharm Res. 2010;27:2162\u201374.","DOI":"10.1007\/s11095-010-0219-2"},{"issue":"2","key":"4010_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bcp.2014.06.017","volume":"91","author":"R Ramer","year":"2014","unstructured":"Ramer R, Fischer S, Haustein M, Manda K, Hinz B. Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Biochem Pharmacol. 2014;91(2):202\u201316.","journal-title":"Biochem Pharmacol"},{"key":"4010_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00114","volume":"8","author":"S Yasmin-Karim","year":"2018","unstructured":"Yasmin-Karim S, Moreau M, Mueller R, Sinha N, Dabney R, Herman A, et al. Enhancing the therapeutic efficacy of cancer treatment with cannabinoids. Front Oncol. 2018;8:114.","journal-title":"Front Oncol"},{"issue":"12","key":"4010_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126766","volume":"23","author":"L Mili\u00e1n","year":"2022","unstructured":"Mili\u00e1n L, Monle\u00f3n-Guinot I, Sancho-Tello M, Galbis JM, Cremades A, Almenar-Ordaz M, et al. In vitro effect of \u22069-tetrahydrocannabinol and cannabidiol on cancer-associated fibroblasts isolated from lung cancer. Int J Mol Sci. 2022;23(12):6766.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4010_CR36","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.21037\/tlcr-22-247","volume":"11","author":"M Vidlarova","year":"2022","unstructured":"Vidlarova M, Berta E, Prasil P, Prokopova A, Gurska S, Khoylou M, et al. Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival. Transl Lung Cancer Res. 2022;11(10):2040.","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"4010_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/ph17111465","volume":"17","author":"F Li","year":"2024","unstructured":"Li F, Gong H, Jia X, Gao C, Jia P, Zhao X, et al. RNAi screen identifies AXL inhibition combined with cannabinoid WIN55212-2 as a potential strategy for cancer treatment. Pharmaceuticals. 2024;17(11):1465.","journal-title":"Pharmaceuticals"},{"issue":"12","key":"4010_CR38","doi-asserted-by":"publisher","first-page":"e2450391","DOI":"10.1001\/jamanetworkopen.2024.50391","volume":"7","author":"MM Nayak","year":"2024","unstructured":"Nayak MM, Chai P, Catalano PJ, Pirl WF, Tulsky JA, Tung SC, et al. Cannabidiol for scan-related anxiety in women with advanced breast cancer: a randomized clinical trial. JAMA Netw Open. 2024;7(12):e2450391\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"4010_CR39","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.annonc.2020.07.020","volume":"31","author":"P Grimison","year":"2020","unstructured":"Grimison P, Mersiades A, Kirby A, Lintzeris N, Morton R, Haber P, et al. Oral THC: CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Ann Oncol. 2020;31(11):1553\u201360.","journal-title":"Ann Oncol"},{"issue":"1","key":"4010_CR40","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1186\/s12885-025-14175-z","volume":"25","author":"M Esmaeli","year":"2025","unstructured":"Esmaeli M, Dehabadi MD, Khaleghi AA. Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature. BMC Cancer. 2025;25(1):772.","journal-title":"BMC Cancer"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04010-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:48:43Z","timestamp":1761119323000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-04010-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4010"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04010-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.The authors have carefully addressed ethical considerations, including monitoring for text plagiarism, duplicate publications, research misconduct, data fabrication, and falsification.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}